|
QPS’s IND Package provides a comprehensive, strategically guided preclinical program, including pharmacology, toxicology, and ADME studies, to thoroughly evaluate drug candidates and support a smooth, timely path to IND/CTA submission.
With expert scientific teams, regulatory support, and end-to-end program management, QPS ensures efficient study execution, high-quality data, and seamless transition from preclinical development to first-in-human clinical trials.
|